RT Journal Article
T1 Standardized brain tumor reporting in the multidisciplinary spotlight: pros of the BT-RADS
A1 Ramos González, Ana
A1 Hilario Barrio, Amaya
AB The RANO criteria were developed specifically in the context of clinical trials, and BT-RADS is designed to be a more clinically applicable counterpart to assess imaging response in gliomas after treatment. As an advantage, BT-RADS is emerging as a reporting system designed to standardize MRI reporting of brain tumors in routine clinical practice with a good interrater reliability and multiple benefits in the quality of radiological reports. There are not only benefits related to radiologist-physician communication and to the length of time spent on each report, but the use of BT-RADS also makes the radiologist a key player in clinical decision-making since it includes treatment recommendations that could be used as a guide for patient management and can serve as a prognostic marker for overall survival in high-grade gliomas. Although this structured reporting system for brain tumor surveillance has shown to improve the quality of MRI reports and clinical decision-making, furtherresearch with larger patient populations, longer follow-up, and optimal incorporation of molecular markers is needed.
PB Springer Nature Link
SN 0938-7994
YR 2024
FD 2024-10
LK https://hdl.handle.net/20.500.14352/116289
UL https://hdl.handle.net/20.500.14352/116289
LA eng
NO Ramos A, Hilario A. Standardized brain tumor reporting in the multidisciplinary spotlight: pros of the BT-RADS. Eur Radiol. 2024 Oct;34(10):6776-6778.
DS Docta Complutense
RD 11 abr 2025